期刊文献+

HGF和1,25-(OH)_2VitD_3对兔骨髓基质干细胞成骨活性的联合诱导 被引量:1

OSTEOGENIC DIFFERENTION CAPACTIY OF RABBIT BONE MARROW STROMAL CELLS INDUCCD BY HGF AND 1,25-(OH)_2VITD_3
下载PDF
导出
摘要 目的观察肝细胞生长因子(HGF)和1,25-(OH)2VitD3对兔骨髓基质干细胞(bone marrow stromal cells,BMSCs)成骨活性的诱导作用。方法采用HGF和1,25-(OH)2VitD3联合诱导兔BMSCs后检测其碱性磷酸酶(alkaline phosphatase,ALP)活性、骨钙素和胶原蛋白I、II的含量并观察其成骨分化特性的变化。结果HGF和1,25-(OH)2VitD3联合诱导的兔BMSCs的ALP活性、骨钙素水平和胶原蛋白I、II在细胞中表达水平均明显高于对照组细胞。结论HGF和1,25-(OH)2VitD3联合诱导作用可以促使兔BMSCs明显表现出成骨分化特性。 Objective To investigate the oseogenic capacity of rabbit BMSCs (bome marrow stromal cells) induced by HGF (hepatocyte growth factor) and 1,25 - (OH)2VitD3. Methods the rabbit BMSCs was cultured in vitro and induced by HGF and 1,25 - (OH)2VitD3, then the osteogcnic differentiation capacity had been cultured by detecting the activation of ALP (alkalie phosphatae ) and the expression of osteocalcin and collagen Ⅰ and Ⅱ. Results The activation of ALP and expression of osteocalcin and collagen Ⅰ and Ⅱ of BMSCs induced by HGF and 1,25 - (OH) 2 VitD3 were obviously higher than those of the control at different experiment time ( P 〈 0.01 ). Conclusion the ostengenic differentiation capacity of BMSCs could be induced by HGF and 1,25 - (OH)2VitD3.
出处 《青海医学院学报》 CAS 2007年第4期240-243,276,共5页 Journal of Qinghai Medical College
关键词 骨髓基质干细胞 HGF 1 25-(OH)2VitD3 成骨分化 成骨诱导 Bone marrow stromal cells HGF 1,25 - (OH)2 VitD3 Osteogenic capacity Ostengenic induction
  • 相关文献

参考文献1

二级参考文献13

  • 1吴德升,赵定麟,何北平,杜晓冰.修复周围神经缺损的组织工程研究[J].生物医学工程学杂志,1997,14(2):108-110. 被引量:20
  • 2Yang L J, Jin L. Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions[ J ]. Clin Orthop,1990, 257: 249-56.
  • 3Kawamura M, Urist MR. Human fibrin is a physiologic delivery system for bone morphogenetic protein[J]. Clin Orthop, 1988, 235: 302-10.
  • 4Maysinger D, Krieglstein K, Filipovic G J, et al. Microencapsulated ciliary nourotrophic factor: physical properties and biological activities[J]. Exp Neurol, 1996, 138(2): 177-88.
  • 5Hiraki Y, Inoue H, Shigeno C. Bone morphogenetic protein (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cell in vitro[J]. J Bone Miner Res, 1991, 6(12): 1373-85.
  • 6Cook SD, Dalton JE, Tan EH, et ol. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions[J]. Spine, 1994, 19(15): 1655-63.
  • 7Groot JD. Carriers that concentrate native bone morphogenetic protein in vivo[J]. Tissue Eng, 1998, 4(4): 337-41.
  • 8Lee EO, Kim JD. Palmitoyl lysozyme-induced stabilization of PE(phosphatidylethanolamine) liposomes and their interaction with Candida albicans[J]. J Biochem, 1995, 117(1): 54-8.
  • 9Rodriguez ML, Holgado MA, Sanchez LC, et al. Alginatc/chitosan particulate systems for sodium diclofenac release[J]. Int J Pharm,2002, 232(1-2): 225-34.
  • 10Reddi AH.Role ofmorphogenefic proteins in skeletal tissue engineering and regeneration[J]. Nat Biotechnol, 1998,16(3): 247-5Z.

共引文献6

同被引文献3

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部